RESUMEN
PML nuclear bodies (NBs) are nuclear matrix-associated structures altered by viruses and oncogenes. We show here that PML overexpression induces rapid cell death, independent of de novo transcription and cell cycling. PML death involves cytoplasmic features of apoptosis in the absence of caspase-3 activation, and caspase inhibitors such as zVAD accelerate PML death. zVAD also accelerates interferon (IFN)-induced death, suggesting that PML contributes to IFN-induced apoptosis. The death effector BAX and the cdk inhibitor p27KIP1 are novel NB-associated proteins recruited by PML to these nuclear domains, whereas the acute promyelocytic leukaemia (APL) PML/RAR alpha oncoprotein delocalizes them. Arsenic enhances targeting of PML, BAX and p27KIP1 to NBs and synergizes with PML and IFN to induce cell death. Thus, cell death susceptibility correlates with NB recruitment of NB proteins. These findings reveal a novel cell death pathway that neither requires nor induces caspase-3 activation, and suggest that NBs participate in the control of cell survival.
Asunto(s)
Apoptosis/fisiología , Proteínas de Ciclo Celular , Proteínas de Neoplasias/fisiología , Proteínas Nucleares , Proteínas Proto-Oncogénicas c-bcl-2 , Factores de Transcripción/fisiología , Proteínas Supresoras de Tumor , Animales , Apoptosis/efectos de los fármacos , Apoptosis/genética , Arsénico/farmacología , Caspasa 3 , Caspasas/fisiología , Núcleo Celular/fisiología , Células Cultivadas , Inhibidor p27 de las Quinasas Dependientes de la Ciclina , Inhibidores de Cisteína Proteinasa/farmacología , Activación Enzimática , Expresión Génica , Humanos , Interferón Tipo I/farmacología , Proteínas Asociadas a Microtúbulos/metabolismo , Proteínas de Neoplasias/genética , Proteína de la Leucemia Promielocítica , Proteínas Proto-Oncogénicas/metabolismo , Ratas , Proteínas Recombinantes , Factores de Transcripción/genética , Proteína X Asociada a bcl-2RESUMEN
Following prolonged mitotic spindle disruption by microtubule poisons, mammalian cells delay their entry into anaphase, then progressively slip out of mitosis and become tetraploid. Normal cells then stop cycling before S-phase onset, but the mechanisms underlying this arrest are still unclear. Here we show that a double block prevents endo-reduplication. First, cells that exit mitosis without a functional microtubule network are driven toward G0. Reconstitution of the network unmasks a second block that relies on DNA double-strand breaks occurring early in the G1 phase that follows the mitotic block. We propose that a stress signal elicited upon mitotic impairment triggers breakage, which couples the leaky spindle checkpoint to the stringent DNA damage response. Consistent with this finding, cells defective for the damage response continue cycling and acquire, within a single cell cycle, both chromosome rearrangements and abnormal chromosome numbers that remarkably mimic the complex genetic hallmark of tumorigenesis.
Asunto(s)
Cromosomas , Daño del ADN , Mitosis/fisiología , Ploidias , Adenocarcinoma/patología , Anafase , Animales , Antineoplásicos/farmacología , Células Cultivadas , Neoplasias del Colon/patología , Cricetinae , Cricetulus , Roturas del ADN de Doble Cadena , Fibroblastos/fisiología , Fase G1/genética , Reordenamiento Génico , Humanos , Immunoblotting , Hibridación Fluorescente in Situ , Pulmón/fisiología , Microtúbulos , Mitosis/efectos de los fármacos , Índice Mitótico , Nocodazol/farmacología , Fase de Descanso del Ciclo Celular , Huso AcromáticoRESUMEN
Three hepatitis B viruses infecting humans, woodchucks and ground squirrels increase the risk of hepatocellular carcinoma in their respective hosts. The woodchuck hepatitis B virus (WHV), unlike the two other viruses, induces a rapid carcinogenic process characterized by direct activation of myc proto-oncogenes by insertion of viral DNA. The highly preferred target of insertional mutagenesis in woodchucks is N-myc2, an intronless N-myc gene. Strikingly, N-myc2 has no human homolog and the homologous N-myc2 locus previously detected in the ground squirrel genome, remains silent during hepatocarcinogenesis. Therefore, N-myc2 may represent a critical host determinant in the evolution of the disease associated with hepadnavirus infection. To address this question, we performed a structural and functional analysis of the ground squirrel N-myc2 locus. We show that ground squirrel N-myc2 is highly homologous to its woodchuck counterpart and is a functional proto-oncogene. Existence of a functional N-myc2 gene as a potential target for insertional activation by viral DNA is therefore not restricted to the woodchuck species. This suggests that viral rather than host factors determine the higher oncogenic phenotype of WHV as compared to the two other mammalian hepadnaviruses.
Asunto(s)
Genes myc , Hepadnaviridae/patogenicidad , Neoplasias Hepáticas Experimentales/virología , Retroelementos , Sciuridae/genética , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Secuencia Conservada , ADN Viral , Neoplasias Hepáticas Experimentales/genética , Datos de Secuencia Molecular , Proto-Oncogenes Mas , Ratas , Ratas Endogámicas F344 , Homología de Secuencia de Aminoácido , Transcripción GenéticaRESUMEN
PML is a nuclear matrix protein with growth suppressing properties, whose expression is deregulated during oncogenesis. Moreover, in the t(15;17) translocation of acute promyelocytic leukaemia (APL), PML fusion to the retinoic acid receptor alpha (RAR alpha) is the likely molecular basis of leukaemogenesis. Here we show that interferons (IFNs) alpha, beta, and gamma upregulate PML mRNA expression. Analysis of 5' genomic sequences of the PML gene revealed an IFN-alpha/-beta stimulated response element (ISRE) and an IFN-gamma activation site (GAS) in the untranslated first exon. Binding of IFN signal transducers and activators of transcription (STATs) was demonstrated to be weak for the PML GAS, but strong for the PML ISRE which also seemed to contribute substantially to the IFN-gamma response. Thus, PML is a primary target gene of IFNs and would appear as a suitable candidate for mediating some of their antiproliferative effects. Abnormalities of PML structure, localisation or expression in human malignancy, constitute examples of how an IFN target gene may be altered in oncogenesis.
Asunto(s)
Interferones/farmacología , Proteínas de Neoplasias , Proteínas Nucleares , Regiones Promotoras Genéticas , Factores de Transcripción/genética , Transcripción Genética/efectos de los fármacos , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Células CHO , Cricetinae , Células HeLa , Humanos , Datos de Secuencia Molecular , Proteína de la Leucemia Promielocítica , Proteínas Supresoras de TumorRESUMEN
Altered sub-nuclear localisation of the nuclear body-associated PML protein in acute promyelocytic leukaemia, has been proposed to contribute to leukaemogenesis. We have recently shown that PML is a primary target gene of interferons. Here, it is shown that PML has growth suppressive properties and displays an altered expression pattern during human oncogenesis. PML is widely expressed in cell-lines and is cell-cycle regulated. Overexpression of the protein induces a sharp reduction in growth rates in vitro and in vivo. In contrast with cell-lines, in normal tissues (including those that rapidly proliferate) only a few cells have detectable PML levels. However, these can be upregulated by soluble factors (e.g. IFN, estrogens). Human epithelial tumors show a gradual increase of PML levels as the lesion progresses from benign dysplasia to carcinoma. A similar induction is found in the surrounding stroma and vessels, which likely results from paracrine interactions. Strikingly, when malignant cells turn invasive, they loose PML expression, while expression is conserved in the stromal compartment. These observations point to the existence of a consistent deregulation in the expression of the PML growth-suppressor during human oncogenesis.
Asunto(s)
Ciclo Celular , Inhibidores de Crecimiento , Proteínas de Neoplasias , Neoplasias/metabolismo , Proteínas Nucleares , Factores de Transcripción/metabolismo , Animales , Estrógenos/fisiología , Femenino , Humanos , Inmunohistoquímica , Técnicas In Vitro , Ratones , Ratones Desnudos , Trasplante de Neoplasias , Proteína de la Leucemia Promielocítica , Piel/metabolismo , Trasplante Heterólogo , Células Tumorales Cultivadas , Proteínas Supresoras de TumorRESUMEN
One of the most frequent genetic abnormalities associated with non Hodgkin lymphoma is the structural alteration of the 5' non coding/regulatory region of the BCL6 (LAZ3) protooncogene. BCL6 encodes a POZ/Zn finger protein, a structure similar to that of many Drosophila developmental regulators and to another protein involved in a human hematopoietic malignancy, PLZF. BCL6 is a sequence specific transcriptional repressor controlling germinal center formation and T cell dependent immune response. Although the expression of BCL6 negatively correlates with cellular proliferation in different cell types, the influence of BCL6 on cell growth and survival is currently unknown so that the way its deregulation may contribute to cancer remains elusive. To directly address this issue, we used a tetracycline-regulated system in human U2OS osteosarcoma cells and thus found that BCL6 mediates growth suppression associated with impaired S phase progression and apoptosis. Interestingly, overexpressed BCL6 can colocalize with sites of ongoing DNA synthesis, suggesting that it may directly interfere with S phase initiation and/or progression. In contrast, the isolated Zn finger region of BCL6, which binds BCL6 target sequence but lacks transcriptional repression activity, slows, but does not suppress, U2OS cell growth, is less efficient at delaying S phase progression, and does not trigger apoptosis. Thus, for a large part, the effects of BCL6 overexpression on cell growth and survival depend on its ability to engage protein/protein interactions with itself and/or its transcriptional corepressors. That BCL6 restricts cell growth suggests that its deregulation upon structural alterations may alleviate negative controls on the cell cycle and cell survival.
Asunto(s)
Apoptosis/fisiología , Replicación del ADN/fisiología , Proteínas de Unión al ADN/fisiología , Proteínas Proto-Oncogénicas/fisiología , Fase S/fisiología , Factores de Transcripción/fisiología , Replicación del ADN/genética , Proteínas de Unión al ADN/genética , Humanos , Proteínas Proto-Oncogénicas/genética , Proteínas Proto-Oncogénicas c-bcl-6 , Factores de Transcripción/genética , Células Tumorales CultivadasRESUMEN
PML has been identified through its fusion to the RAR alpha gene in acute promyelocytic leukemia (APL). The PML protein is specifically associated to nuclear bodies (NBs) whose alterations in APL were proposed to contribute to leukemogenesis. The role of this nuclear domain (which also harbors the Sp100 autoantigen and the NDP52 protein) is unknown. Here, we show that the PML protein, like Sp100 and NDP52, is induced by interferons (IFNs alpha, beta and gamma) in a large variety of human cells. Interestingly, the NBs that contain the three IFN-induced proteins appear to be associated to speckles labelled by the IFN-mediator Mx1. These observations link NBs to IFN response pathways, which may contribute to the elucidation of the biological role of these structures. In APL cells, IFNs induced both PML and PML/RAR alpha expression, resulting in an increased sequestration of PML and RXRs in the microspeckles induced by the fusion protein. As PML has growth suppressing properties, it may mediate some of the antiproliferative effects of IFN. In APL, inactivation of PML may result in disruption of growth control.
Asunto(s)
Antineoplásicos/farmacología , Proteínas de Unión al GTP , Interferones/farmacología , Leucemia Promielocítica Aguda/metabolismo , Proteínas de Neoplasias , Proteínas/metabolismo , Factores de Transcripción/biosíntesis , Western Blotting , Humanos , Microscopía Confocal , Proteínas de Resistencia a Mixovirus , Proteínas Nucleares/biosíntesis , Proteína de la Leucemia Promielocítica , Células Tumorales Cultivadas , Proteínas Supresoras de TumorRESUMEN
PML (promyelocytic leukemia) is a protein involved in the t (15;17) translocation of promyelocytic leukemia and is mainly localized in nuclear bodies. Here we show that PML exerts a very powerful enhancing activity (up to 20-fold) on the transactivating properties of the progesterone receptor (PR) and has a similar effect on several other steroid hormone receptors. There is probably a direct or indirect interaction between PR and PML, because when the latter was expressed at high concentrations it shifted PR into the nuclear bodies. The use of deletion mutants showed that both activation functions (AF1 and AF2) of PR as well as the coiled coil and His-Cys-rich domains of PML were required for transcriptional enhancement. The fusion protein PML-RAR which is not localized in nuclear bodies, also enhanced the transactivating activity of PR, but this effect was totally suppressed by the administration of retinoic acid. PML, which is ubiquitously expressed, may thus be involved in the transactivation properties of steroid hormone receptors. This mechanism may also play a role in the oncogenic properties of PML-RAR and in their suppression by retinoic acid.
Asunto(s)
Proteínas de Neoplasias , Proteínas Nucleares , Receptores de Ácido Retinoico/fisiología , Factores de Transcripción/farmacología , Animales , Secuencia de Bases , Células CHO , Línea Celular , Cricetinae , Células HeLa , Humanos , Datos de Secuencia Molecular , Proteína de la Leucemia Promielocítica , Receptores de Progesterona/genética , Receptores de Progesterona/fisiología , Receptores de Ácido Retinoico/genética , Proteínas Recombinantes de Fusión , Factores de Transcripción/genética , Factores de Transcripción/metabolismo , Transcripción Genética/efectos de los fármacos , Activación Transcripcional , Transfección , Proteínas Supresoras de TumorRESUMEN
Experiments designed according to Doehlert matrices were carried out to study poliovirus-1 adsorption to Na-montmorillonite in a complex aqueous environment. Salt concentration and valence, virus load, clay concentration, and organic matter concentration were included in the design as selected parameters for possible or known involvement in viral adsorption in environmental waters. Use of this experimental design not only allowed to detect and quantify direct influence of the tested parameters upon the viral response, but also to reveal the influence of interactions between these tested factors. Thus, beyond the reassessment of the higher efficiency of multivalent cations on virus adsorption, as opposed to monovalent ones, detection was enabled of a tannic acid/aluminium specific interaction that seemed to be responsible for the nonavailability of these elements for interaction with viruses. Such a statistical tool allows for a gain in experimental accuracy beyond technical improvements and is particularly suited for low-cost study of multifactorial phenomena.
Asunto(s)
Silicatos de Aluminio , Poliovirus/aislamiento & purificación , Adsorción , Animales , Línea Celular , Chlorocebus aethiops , Arcilla , Humanos , Taninos Hidrolizables , Modelos Biológicos , Proyectos de InvestigaciónRESUMEN
PML is a protein involved in the t (15, 17) translocation of promyelocytic leukemia and is mainly localized in nuclear bodies. Here we show that PML exerts a very powerful enhancing activity (up to 20-fold) on the transactivating properties of the progesterone receptor (PR) and has a similar effect on several other steroid hormone receptors. There is probably a direct or indirect interaction between PR and PML since when the latter was expressed at high concentrations it shifted PR into the nuclear bodies. Use of deletion mutants showed that both activation functions (AF1 and AF2) of PR as well as the coiled coil and His-Cys rich domains of PML were required for transcriptional enhancement. The fusion protein PML-RAR, which is not localized in nuclear bodies, also enhanced the transactivating activity of PR but this effect was totally suppressed by the administration of retinoic acid. PML, which is ubiquitously expressed, may thus be involved in the transactivation properties of steroid hormone receptors. This mechanism may also play a role in the oncogenic properties of PML-RAR and in their suppression by the retinoic acid.
Asunto(s)
Leucemia Promielocítica Aguda/genética , Proteínas de Neoplasias/farmacología , Proteínas Nucleares , Proteínas de Fusión Oncogénica/farmacología , Receptores de Esteroides/genética , Factores de Transcripción/farmacología , Técnicas In Vitro , Receptores de Progesterona/análisis , Receptores de Progesterona/genética , Receptores de Progesterona/metabolismo , Fracciones Subcelulares/metabolismo , Distribución Tisular , Factores de Transcripción/genética , Transcripción Genética/efectos de los fármacos , Activación Transcripcional , Proteínas Supresoras de TumorAsunto(s)
Leucemia Promielocítica Aguda/terapia , Proteínas de Neoplasias , Proteínas Nucleares , Receptores de Ácido Retinoico/fisiología , Factores de Transcripción/fisiología , Tretinoina/fisiología , Animales , Arsénico , Fusión Artificial Génica , Transformación Celular Neoplásica , Humanos , Leucemia Promielocítica Aguda/fisiopatología , Proteína de la Leucemia Promielocítica , Receptor alfa de Ácido Retinoico , Translocación Genética , Proteínas Supresoras de TumorRESUMEN
ATP-dependent SWI/SNF chromatin remodeling complexes regulate cell-cycle and play critical roles in a variety of differentiation pathways. The core subunit SNF5/INI1 is a tumor suppressor that is inactivated in a highly aggressive childhood cancer of unknown cellular origin, termed malignant rhabdoid tumor (MRT). The highly undifferentiated phenotype of this tumor suggests that the loss-of-function of hSNF5/INI1 impairs specific differentiation programs of the MRT parental cell. Based on the hypothesis that these programs might be reinitialized upon hSNF5/INI1 re-expression in MRTs, we show that some MRT cell lines can differentiate toward the adipogenic lineage. We further show that the knock down of the SNF5/INI1 subunit abrogates adipocyte differentiation of murine 3T3-L1 preadipocytes and of human mesenchymal stem cells. Finally, we provide evidence that hSNF5/INI1 cooperates with C/EBPbeta and PPARgamma2 transcriptional regulators to activate the expression of adipocyte-specific genes. These data indicate that not only the ATPase subunit of the SWI/SNF complex, but also SNF5/INI1 is required for adipocyte differentiation. They further show that MRT cell lines harbor an adipogenic differentiation potential and that the tumor suppressor role of the SNF5/INI1 subunit may rely on its ability to regulate the balance between cell proliferation and differentiation.
Asunto(s)
Adipogénesis/genética , Proteínas Cromosómicas no Histona/metabolismo , Proteínas de Unión al ADN/metabolismo , Tumor Rabdoide/genética , Tumor Rabdoide/patología , Factores de Transcripción/metabolismo , Proteínas Supresoras de Tumor/metabolismo , Células 3T3-L1 , Adipocitos/citología , Adipocitos/metabolismo , Animales , Proteína beta Potenciadora de Unión a CCAAT/metabolismo , Línea Celular Tumoral , Proliferación Celular , Ensamble y Desensamble de Cromatina , Proteínas Cromosómicas no Histona/antagonistas & inhibidores , Proteínas Cromosómicas no Histona/genética , Proteínas de Unión al ADN/antagonistas & inhibidores , Proteínas de Unión al ADN/genética , Humanos , Ratones , PPAR gamma/metabolismo , Proteína SMARCB1 , Factores de Transcripción/antagonistas & inhibidores , Factores de Transcripción/genética , Proteínas Supresoras de Tumor/antagonistas & inhibidores , Proteínas Supresoras de Tumor/genéticaRESUMEN
A pilot-scale study was initiated to examine the behavior of viruses pulse injected into a distribution system. The influence of a free-chlorine residual and that of virus preadsorption to clay particles was evaluated by tracing the viruses both in the water flow and after elution from the biofilm. These experiments demonstrated, first, that virus preadsorption on 40 mg of Na-montmorillonite per liter increased the residence time of the viruses within the pilot plant by roughly three times and, second, that preadsorption to clay did not prevent viruses from being inactivated by chlorine. Moreover, with no clay added, a greater amount of viruses was recovered from the biofilm than from the water flow (by a factor of 2 or 10 in the absence or presence of chlorine, respectively), indicating a tendency for virus accumulation within biofilms.
Asunto(s)
Biopelículas , Poliovirus , Activación Viral , Microbiología del Agua , Humanos , Poliovirus/química , Poliovirus/fisiología , Porfirinas , Virión/química , Virión/fisiologíaRESUMEN
After heat, conductivity has been described as the second most inactivating factor of viruses in surface waters. Using poliovirus-1, we showed that a highly significant linear relationship between virus inactivation rate and water conductivity can be obtained for most of the tested sterilized water samples. Using sterile saline solutions, we demonstrated that this apparent relationship is false, i.e., virus inactivation rate is not affected by water conductivity alone. With the hypothesis that salts may serve to potentiate the antiviral activities of certain microbiological substances that are supposed to be found in the tested samples, we can explain the apparent relationship observed in this study and in similar ones. As a consequence, an effective water treatment could be responsible for the removal of both viruses and some virus-inactivating factors. Alternatively, virus-inactivating capability of a given water resource could be enhanced along with its hardness or its degree of mineralization.
Asunto(s)
Antivirales/farmacología , Poliovirus/efectos de los fármacos , Agua/farmacología , Conductividad Eléctrica , Agua Dulce , EsterilizaciónRESUMEN
The interferon (IFN)-induced promyelocytic leukemia (PML) protein is specifically associated with nuclear bodies (NBs) whose functions are yet unknown. Two of the NB-associated proteins, PML and Sp100, are induced by IFN. Here we show that overexpression of PML and not Sp100 induces resistance to infections by vesicular stomatitis virus (VSV) (a rhabdovirus) and influenza A virus (an orthomyxovirus) but not by encephalomyocarditis virus (a picornavirus). Inhibition of viral multiplication was dependent on both the level of PML expression and the multiplicity of infection and reached 100-fold. PML was shown to interfere with VSV mRNA and protein synthesis. Compared to the IFN mediator MxA protein, PML had less powerful antiviral activity. While nuclear body localization of PML did not seem to be required for the antiviral effect, deletion of the PML coiled-coil domain completely abolished it. Taken together, these results suggest that PML can contribute to the antiviral state induced in IFN-treated cells.
Asunto(s)
Antígenos Nucleares , Virus de la Influenza A , Gripe Humana/metabolismo , Interferones/farmacología , Proteínas de Neoplasias , Infecciones por Rhabdoviridae/metabolismo , Factores de Transcripción/metabolismo , Virus de la Estomatitis Vesicular Indiana , Animales , Autoantígenos/metabolismo , Células CHO , Cricetinae , Susceptibilidad a Enfermedades , Humanos , Proteínas Nucleares/metabolismo , Proteína de la Leucemia Promielocítica , Células Tumorales Cultivadas , Proteínas Supresoras de TumorRESUMEN
We have studied at the ultrastructural level the localization of PML protein in response to adenovirus infection in HeLa cells. In nuclei of noninfected cells or at the early stage of infection, PML accumulated at the border of nuclear bodies as previously described [Koken et al. (1994) EMBO J. 13, 1073-1083]. Interestingly, we demonstrate herein that PML is also a component of the interchromatin granule-associated zones, recently described structures containing U1 snRNP [Visa et al. (1993) Eur. J. Cell Biol. 60, 308-321], suggesting that PML protein might be involved in some steps of splicing events. However, as the infection progressed these two cellular PML-containing structures disappeared but significant amounts of PML accumulated within two virus-induced structures, essentially the clear amorphous inclusions, but also the protein crystals. Relocalization of this protein to virus-induced structures may reflect an inactivation of PML functions.
Asunto(s)
Adenovirus Humanos/genética , Núcleo Celular/metabolismo , Núcleo Celular/ultraestructura , Proteínas de Neoplasias , Proteínas Nucleares , Factores de Transcripción/metabolismo , Western Blotting , Transformación Celular Viral , Técnica del Anticuerpo Fluorescente , Células HeLa , Humanos , Microscopía Electrónica , Proteína de la Leucemia Promielocítica , Factores de Transcripción/análisis , Proteínas Supresoras de TumorRESUMEN
Human T-cell lymphotropic virus type I (HTLV-I)-associated adult T-cell leukemia/lymphoma (ATL) is a malignancy of mature activated T cells resistant to conventional chemotherapy. The viral transactivator protein Tax plays a critical role in HTLV-I-induced transformation and apoptosis resistance by inducing I kappa B-alpha degradation, resulting in the activation of the NF-kappa Bpathway. In these HTLV-I-transformed cells, arsenic trioxide (As) and interferon (IFN)-alpha synergize to induce cell cycle arrest and apoptosis. We demonstrate that cell death induction is only partly dependent upon caspase activation and is not associated with modulation of bcl-2, bax, or p53 expression. However, combined As and IFN induce the degradation of Tax, associated with an up-regulation of I kappa B-alpha resulting in a sharp decrease in RelA DNA binding nuclear factor (NF)-kappa B complexes because of the cytoplasmic retention of RelA. Taken the role of Tax in HTLV-I-induced transformation, its down-regulation probably accounts for cell death induction through inactivation of the NF-kappa B pathway. Such specific targeting of the viral oncoprotein by As-IFN treatment, reminiscent of As targeting of promyelocytic leukemia/retinoic acid receptor-alpha in acute promyelocytic leukemia, provides strong rational for combined As-IFN therapy in ATL patients. (Blood. 2000;96:2849-2855)
Asunto(s)
Apoptosis/efectos de los fármacos , Arsenicales/farmacología , Transformación Celular Viral/efectos de los fármacos , Regulación Leucémica de la Expresión Génica/efectos de los fármacos , Regulación Viral de la Expresión Génica/efectos de los fármacos , Productos del Gen tax/fisiología , Virus Linfotrópico T Tipo 1 Humano/fisiología , Proteínas I-kappa B , Interferón-alfa/farmacología , Leucemia-Linfoma de Células T del Adulto/genética , FN-kappa B/metabolismo , Proteínas de Neoplasias/fisiología , Óxidos/farmacología , Activación Transcripcional/efectos de los fármacos , Trióxido de Arsénico , Caspasas/fisiología , Ciclo Celular/efectos de los fármacos , Línea Celular Transformada , ADN/metabolismo , Proteínas de Unión al ADN/genética , Proteínas de Unión al ADN/metabolismo , Sinergismo Farmacológico , Activación Enzimática , Humanos , Leucemia-Linfoma de Células T del Adulto/patología , Ligasas/metabolismo , Sustancias Macromoleculares , Inhibidor NF-kappaB alfa , Linfocitos T/metabolismo , Linfocitos T/virología , Células Tumorales CultivadasRESUMEN
Acute promyelocytic leukemia (APL) is associated with the t(15;17) translocation, which generates a PML/RAR alpha fusion protein between PML, a growth suppressor localized on nuclear matrix-associated bodies, and RAR alpha, a nuclear receptor for retinoic acid (RA). PML/RAR alpha was proposed to block myeloid differentiation through inhibition of nuclear receptor response, as does a dominant negative RAR alpha mutant. In addition, in APL cells, PML/RAR alpha displaces PML and other nuclear body (NB) antigens onto nuclear microspeckles, likely resulting in the loss of PML and/or NB functions. RA leads to clinical remissions through induction of terminal differentiation, for which the respective contributions of RAR alpha (or PML/RAR alpha) activation, PML/RAR alpha degradation, and restoration of NB antigens localization are poorly determined. Arsenic trioxide also leads to remissions in APL patients, presumably through induction of apoptosis. We demonstrate that in non-APL cells, arsenic recruits the nucleoplasmic form of several NB antigens onto NB, but induces the degradation of PML only, identifying a powerful tool to approach NB function. In APL cells, arsenic targets PML and PML/RAR alpha onto NB and induces their degradation. Thus, RA and arsenic target RAR alpha and PML, respectively, but both induce the degradation of the PML/RAR alpha fusion protein, which should contribute to their therapeutic effects. The difference in the cellular events triggered by these two agents likely stems from RA-induced transcriptional activation and arsenic effects on NB proteins.
Asunto(s)
Arsénico/farmacología , Núcleo Celular/metabolismo , Leucemia Promielocítica Aguda/metabolismo , Proteínas de Neoplasias/metabolismo , Proteínas de Fusión Oncogénica/metabolismo , Apoptosis/efectos de los fármacos , Transporte Biológico/efectos de los fármacos , Humanos , Leucemia Promielocítica Aguda/patología , Leucemia Promielocítica Aguda/terapiaRESUMEN
Analyzing the pathways by which retinoic acid (RA) induces promyelocytic leukemia/retinoic acid receptor alpha (PML/RARalpha) catabolism in acute promyelocytic leukemia (APL), we found that, in addition to caspase-mediated PML/RARalpha cleavage, RA triggers degradation of both PML/RARalpha and RARalpha. Similarly, in non-APL cells, RA directly targeted RARalpha and RARalpha fusions to the proteasome degradation pathway. Activation of either RARalpha or RXRalpha by specific agonists induced degradation of both proteins. Conversely, a mutation in RARalpha that abolishes heterodimer formation and DNA binding, blocked both RARalpha and RXRalpha degradation. Mutations in the RARalpha DNA-binding domain or AF-2 transcriptional activation region also impaired RARalpha catabolism. Hence, our results link transcriptional activation to receptor catabolism and suggest that transcriptional up-regulation of nuclear receptors by their ligands may be a feedback mechanism allowing sustained target-gene activation.
Asunto(s)
Cisteína Endopeptidasas/metabolismo , Complejos Multienzimáticos/metabolismo , Proteínas de Neoplasias/metabolismo , Proteínas de Fusión Oncogénica/metabolismo , Receptores de Ácido Retinoico/metabolismo , Tretinoina/farmacología , Caspasas/metabolismo , Análisis Mutacional de ADN , Dimerización , Leucemia Promielocítica Aguda/metabolismo , Complejo de la Endopetidasa Proteasomal , Receptores de Ácido Retinoico/genética , Receptor alfa de Ácido Retinoico , Receptores X Retinoide , Factores de Transcripción/metabolismoRESUMEN
Acute promyelocytic leukemia (APL) is specifically associated to a t(15; 17) translocation which fuses a gene encoding a nuclear receptor for retinoic acid, RARalpha, to a previously unknown gene PML. The PML protein is localized in the nucleus on a specific domain of unknown function (PML nuclear bodies, NB) previously detected with autoimmune sera from patients with primary biliary cirrhosis (PBC). These bodies are nuclear matrix-associated and all of their identified components (PML, Sp100, and NDP52) are sharply upregulated by interferons. We show that autoantibodies against both PML and Sp100 are usually associated in sera with multiple nuclear dot anti-nuclear antibodies and demonstrate that PML is an autoantigen, not only in PBC, but also in other autoimmune diseases. In APL, the PML/RARalpha fusion interferes with both the retinoic acid (RA) response and PML localization on nuclear bodies, but the respective contribution of each defect to leukemogenesis is unclear. RA induces the terminal differentiation of APL blasts, yielding to complete remissions, and corrects the localization of NB antigens. Arsenic trioxide (As2O3) also induces remissions in APL, seemingly through induction of apoptosis. We show that in APL, As2O3 leads to the rapid reformation of PML bodies. Thus, both agents correct the defect in NB antigen localization, stressing the role of nuclear bodies in the pathogenesis of APL.